Clik here to view.
知临集团首席执行官认购本公司股份
纽约、伦敦和巴黎 (美国商业资讯)–知临集团（纳斯达克股票代码：APM，巴黎泛欧证券交易所代码：APM）（「知临集团」或「知临」），是一家临床阶段的生物制药公司，致力于开发新型疗法以解决全球尚未满足的医疗需求，今天宣布公司创始人，首席执行官兼执行董事禤骏远先生通过其全资投资公司Jurchen Investments...
View ArticleClik here to view.
Engine Biosciences宣布获得超额认购的4300万美元A轮融资，以通过机器学习和新一代组合遗传学破译新药开发遗传密码
新加坡和美国加利福尼亚州圣卡洛斯 Engine Biosciences（“Engine”）于今日宣布成功完成超额认购的4300万美元A轮融资。Engine公司能识别出复杂疾病遗传密码中的错误，并用精确的治疗方案对其进行修复。本轮融资由Polaris...
View ArticleClik here to view.
Engine Biosciences Announces $43 Million Series A Round to Decipher Genetic...
SINGAPORE & SAN CARLOS, Calif. Engine Biosciences (“Engine”) today announced the successful completion of an oversubscribed $43 million Series A funding round. Engine identifies errors in the...
View ArticleClik here to view.
Orum Therapeutics Appoints Jae Won Kim Chief Financial Officer
BOSTON & DAEJEON, South Korea Orum Therapeutics, a global biotech company pioneering the development technologies for precision delivery of targeted protein degraders to treat cancer, today...
View ArticleClik here to view.
武田薬品、EGFRエクソン20挿入変異を伴うmNSCLC患者における臨床効果をさらに裏付けるモボセルチニブの最新結果を発表へ
大阪 & 米マサチューセッツ州ケンブリッジ （ビジネスワイヤ） —...
View ArticleClik here to view.
ONK Therapeutics Secures Exclusive Global License to Patent for CISH Knockout...
GALWAY, Ireland & SAN DIEGO, USA ONK Therapeutics Ltd, an innovative natural killer (NK) cell therapy company, today announced that it has entered into an exclusive global patent license...
View ArticleClik here to view.
NEC’s AI Supports Doctors to Detect Neoplasia in Barrett’s Esophagus During...
TOKYO NEC Corporation (NEC; TOKYO: 6701) today announced the development of an AI technology for supporting doctors to detect neoplasia in Barrett’s esophagus during endoscopic procedures. This is...
View ArticleClik here to view.
NEC的人工智能技术帮助医生在内镜检查时检出巴雷特食管肿瘤
东京 (美国商业资讯)–NEC Corporation (NEC; TOKYO: 6701)今天宣布开发一项人工智能(AI)技术，以帮助医生在内镜检查时检出巴雷特(Barrett)食管肿瘤。这是世界首创的符合欧洲安全、健康和环保标准(*1) CE认证标志要求的技术，以WISE VISION®内镜形式发布，将很快在欧洲上市，用于帮助医生检出巴雷特肿瘤(*2)。...
View ArticleClik here to view.
BeiGene Announces First Presentation of the Phase 3 ALPINE Trial Comparing...
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced...
View ArticleClik here to view.
Sesen Bio Announces Global Supply Partnership with Qilu Pharmaceutical
CAMBRIDGE, Mass. Sesen Bio (Nasdaq: SESN), a late-stage clinical company developing targeted fusion protein therapeutics for the treatment of patients with cancer, today announced that on Tuesday,...
View ArticleClik here to view.
Veristat Appoints Colleen Pelton Chief Talent Officer
SOUTHBOROUGH, Mass. Veristat, a scientific-minded global clinical research organization (CRO), announced the appointment of Colleen Pelton to the role of Chief Talent Officer. Ms. Pelton joins...
View ArticleClik here to view.
Preclinical Studies From Vaxxas and Collaborators Reveal Potential of Vaxxas’...
CAMBRIDGE, Mass. & BRISBANE, Australia Vaxxas, a clinical-stage biotechnology company commercializing a novel vaccination platform, today announced that research demonstrating the potential of...
View ArticleClik here to view.
IASO Receives NMPA Acceptance of its First Indication IND Application for...
PLEASANTON, Calif. & NANJING, China IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and...
View ArticleClik here to view.
Guangzhou Bio-Gene Announces Oral Presentation at the 2021 ASCO Annual Meeting
GUANGZHOU, China Guangzhou Bio-Gene, a clinical-stage biopharmaceutical company developing a pipeline of innovative oncology therapies, today announced the company will present at the 2021 American...
View ArticleClik here to view.
CORRECTING and REPLACING IASO Receives NMPA Acceptance of its First...
PLEASANTON, Calif. & NANJING, China First sentence of release should read: “…has been accepted by the China National Medical Products Administration (NMPA)…” (instead of “…has been approved by...
View ArticleClik here to view.
Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their...
SAN DIEGO Today Invivoscribe, a global leader in precision diagnostics, announced the launch of a new 12-color multiparametric flow cytometry service in Shanghai, China, the newest reference...
View ArticleClik here to view.
Biolog-id to Strengthen Its Presence in India by Opening a Registered Office
PARIS Biolog-id, a global service provider of connected healthcare solutions, announces today the opening of a registered office in the capital city of India, New Delhi. By creating this hub,...
View ArticleClik here to view.
Patritumab Deruxtecan Data at ASCO Demonstrates Tumor Response Across...
TOKYO, MUNICH & BASKING RIDGE, N.J. New data from Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo’s) patritumab deruxtecan (HER3-DXd), a HER3 directed antibody drug conjugate (ADC),...
View ArticleClik here to view.
クラウン・バイオサイエンス、大規模スクリーニングパネルを実現するため、ATCCおよびNIHの定評ある細胞株に対する優先アクセスを発表
サンディエゴ （ビジネスワイヤ） —...
View ArticleClik here to view.
BeiGene Presents Clinical Data from Two Phase 2 Trials of Pamiparib at the...
CAMBRIDGE, Mass. & BEIJING BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a global biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced...
View Article